Renaissance Technologies - CHEMED CORP NEW ownership

CHEMED CORP NEW's ticker is CHE and the CUSIP is 16359R103. A total of 200 filers reported holding CHEMED CORP NEW in Q4 2014. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.

About CHEMED CORP NEW

Chemed Corp New is a publicly traded company that operates in the healthcare industry. The company is headquartered in Cincinnati, Ohio, and is listed on the New York Stock Exchange under the ticker symbol "CHE". Chemed Corp New is the parent company of two subsidiaries, VITAS Healthcare and Roto-Rooter.

VITAS Healthcare is a provider of hospice care services, while Roto-Rooter is a provider of plumbing and drain cleaning services. Both subsidiaries operate in highly competitive markets, but have managed to maintain their market positions through a combination of quality service and effective marketing.

Chemed Corp New has a strong management team, led by CEO Kevin McNamara, who has been with the company since 1999. Under his leadership, the company has grown both organically and through acquisitions, and has consistently delivered strong financial results.

Despite the challenges posed by the COVID-19 pandemic, Chemed Corp New has continued to perform well. In the second quarter of 2021, the company reported revenue of $527 million, an increase of 7.5% compared to the same period in the previous year. Net income for the quarter was $70 million, an increase of 16.7% compared to the same period in the previous year.

Overall, Chemed Corp New is a well-managed company with a strong track record of performance. While there are risks associated with investing in any publicly traded company, Chemed Corp New appears to be well-positioned to continue delivering strong financial results in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CHEMED CORP NEW
ValueSharesWeighting
Q3 2023$40,433
-23.3%
77,800
-20.0%
0.07%
-9.2%
Q2 2023$52,704
-5.9%
97,300
-6.5%
0.08%
+2.7%
Q1 2023$55,980
-7.1%
104,100
-11.9%
0.07%
-9.8%
Q4 2022$60,282
-99.9%
118,100
-11.4%
0.08%0.0%
Q3 2022$58,193,000
-25.3%
133,300
-19.7%
0.08%
-10.9%
Q2 2022$77,916,000
+19.7%
165,995
+29.2%
0.09%
+21.1%
Q1 2022$65,092,000
-5.4%
128,500
-1.2%
0.08%
-11.6%
Q4 2021$68,828,000
+2.4%
130,100
-10.0%
0.09%
-1.1%
Q3 2021$67,210,000
-0.9%
144,500
+1.1%
0.09%
+2.4%
Q2 2021$67,806,000
-23.7%
142,900
-26.0%
0.08%
-23.4%
Q1 2021$88,837,000
-36.1%
193,200
-26.0%
0.11%
-26.5%
Q4 2020$139,011,000
-3.8%
261,000
-13.2%
0.15%
+4.9%
Q3 2020$144,489,000
+0.4%
300,800
-5.7%
0.14%
+16.1%
Q2 2020$143,891,000
+19.5%
319,000
+14.8%
0.12%
+6.0%
Q1 2020$120,399,000
+39.4%
277,929
+41.4%
0.12%
+77.3%
Q4 2019$86,359,000
+7.1%
196,600
+1.8%
0.07%
-2.9%
Q3 2019$80,633,000
-6.7%
193,100
-19.4%
0.07%
-10.5%
Q2 2019$86,457,000
+0.0%
239,598
-11.3%
0.08%
-3.8%
Q1 2019$86,419,000
+17.5%
270,000
+4.0%
0.08%
-2.5%
Q4 2018$73,568,000
-1.5%
259,700
+11.1%
0.08%
+5.2%
Q3 2018$74,683,000
+16.8%
233,690
+11.5%
0.08%
+120.0%
Q2 2018$63,915,000
+227.1%
209,500
+192.6%
0.04%
+66.7%
Q1 2018$19,537,000
+47.8%
71,600
+31.6%
0.02%
+40.0%
Q4 2017$13,220,000
-38.4%
54,400
-48.8%
0.02%
-40.0%
Q3 2017$21,478,000
+49.2%
106,300
+51.0%
0.02%
+38.9%
Q2 2017$14,399,000
+290.2%
70,400
+248.5%
0.02%
+260.0%
Q1 2017$3,690,000
-55.7%
20,200
-61.1%
0.01%
-61.5%
Q4 2016$8,325,000
-37.7%
51,900
-45.3%
0.01%
-45.8%
Q3 2016$13,373,000
-10.8%
94,800
-13.8%
0.02%
-17.2%
Q2 2016$14,994,000
-25.3%
110,000
-25.8%
0.03%
-23.7%
Q1 2016$20,074,000
+55.8%
148,200
+72.3%
0.04%
+35.7%
Q4 2015$12,883,000
+2737.7%
86,000
+2429.4%
0.03%
+2700.0%
Q3 2015$454,000
-89.6%
3,400
-89.8%
0.00%
-90.0%
Q2 2015$4,366,000
-69.3%
33,300
-72.0%
0.01%
-66.7%
Q1 2015$14,209,000
+27.1%
119,000
+12.5%
0.03%
+11.1%
Q4 2014$11,180,000
+21.0%
105,800
+17.8%
0.03%
+8.0%
Q3 2014$9,240,000
+20.1%
89,800
+9.4%
0.02%
+38.9%
Q2 2014$7,694,000
+119.3%
82,100
+109.3%
0.02%
+125.0%
Q1 2014$3,508,00039,2190.01%
Other shareholders
CHEMED CORP NEW shareholders Q4 2014
NameSharesValueWeighting ↓
M.D. Sass, Inc. 67,265$34,957,6214.70%
William Allan Corp 7,508$3,902,0723.09%
Formidable Asset Management, LLC 26,619$13,833,8943.06%
SCHWARTZ INVESTMENT COUNSEL INC 111,666$58,032,8202.48%
Durable Capital Partners LP 483,068$251,050,4402.29%
Van Berkom & Associates Inc. 130,012$67,5672.20%
Trinity Street Asset Management LLP 29,861$15,518,7611.99%
Eukles Asset Management 6,696$3,479,9241.84%
CABOT WEALTH MANAGEMENT INC 23,063$11,9861.84%
NORTH POINT PORTFOLIO MANAGERS CORP/OH 17,030$8,850,2741.81%
View complete list of CHEMED CORP NEW shareholders